PF-739

CAS No. 1852452-14-2

PF-739 ( PF 739;PF739 )

Catalog No. M12861 CAS No. 1852452-14-2

A novel potent, pan-AMPK activator with similar potency for all AMPK heterotrimers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 963 Get Quote
50MG 1962 Get Quote
100MG 2520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PF-739
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent, pan-AMPK activator with similar potency for all AMPK heterotrimers.
  • Description
    A novel potent, pan-AMPK activator with similar potency for all AMPK heterotrimers; increases the phosphorylation of the AMPK substrate ACC at S79 with EC50 of 121 nM, potently inhibits de novo lipogenesis (IC50=25 nM) in primary rat hepatocytes; increases PGC1a transcription and mitochondrial content, effectively activats AMPK in hepatocytes and in skeletal muscle; caused a rapid lowering of plasma glucose levels with no impact on hepatic glucose production in diabetic mice.
  • Synonyms
    PF 739;PF739
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1852452-14-2
  • Formula Weight
    442.90
  • Molecular Formula
    C23H23ClN2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@H]1[C@](OC[C@H]2OC3=NC4=CC(C5=CC=C(C6(CO)CC6)C=C5)=C(Cl)C=C4N3)([H])[C@]2([H])OC1
  • Chemical Name
    (3R,3aR,6R,6aR)-6-((6-chloro-5-(4-(1-(hydroxymethyl)cyclopropyl)phenyl)-1Hbenzo[d]imidazol-2-yl)oxy)hexahydrofuro[3,2-b]furan-3-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cokorinos EC, et al. Cell Metab. 2017 May 2;25(5):1147-1159.
molnova catalog
related products
  • Buformin hydrochlori...

    Buformin hydrochloride is a potent AMPK activator,an oral antidiabetic drug of the biguanide class.

  • WZ4003

    WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively.

  • BC1618

    BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.